Copyright: ©Author(s) 2026.
World J Psychiatry. Sep 19, 2026; 16(9): 116579
Published online Sep 19, 2026. doi: 10.5498/wjp.116579
Published online Sep 19, 2026. doi: 10.5498/wjp.116579
Table 1 General patient data, n (%)
| Indicators | Reference group (n = 56) | Research group (n = 66) | χ2/t | P value |
| Age (years) | 59.96 ± 6.89 | 57.67 ± 8.68 | ||
| Male | 35 (62.50) | 40 (60.61) | 0.046 | 0.830 |
| Body mass index (kg/m2) | 23.34 ± 2.27 | 22.74 ± 2.36 | 1.424 | 0.157 |
| Stroke course (day) | 20.36 ± 5.69 | 22.36 ± 6.27 | 1.831 | 0.070 |
| Infarction site | 0.529 | 0.767 | ||
| Cortical and subcortical | 28 (50.00) | 35 (53.03) | ||
| Brainstem | 15 (26.79) | 14 (21.21) | ||
| Cerebellum | 13 (23.21) | 17 (25.76) | ||
| Hypertension | 15 (26.79) | 20 (30.30) | 0.183 | 0.669 |
| Diabetes | 23 (41.07) | 19 (28.79) | 2.025 | 0.155 |
| Hyperlipidaemia | 11 (19.64) | 15 (22.73) | 0.172 | 0.679 |
- Citation: Zhu ZH, Lin YS, Hong ZQ. Efficacy and influencing factors of 3-N-Butylphthalide-trazodone combination in managing post-ischemic stroke depression. World J Psychiatry 2026; 16(9): 116579
- URL: https://www.wjgnet.com/2220-3206/full/v16/i9/116579.htm
- DOI: https://dx.doi.org/10.5498/wjp.116579